• |
Provide support for witness protection program |
Decision Package |
|
|
Funds a witness protection program. Law enforcement agencies will be able to apply for temporary assistance for witnesses cooperating with the investigation and prosecution of crimes. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$2,500,000 |
|
• |
Increase salary for non-attorney staff |
Decision Package |
|
|
Funds salary increases for non-attorney staff to address salary compression and reduce turnover by raising base pay. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$575,561 |
|
• |
Provide funding for cannabis consumer protection enforcement investigators |
Decision Package |
|
|
Funds cannabis enforcement activities pursuant to the Consumer Protection Act. This includes staff to enforce Virginia Code provisions prohibiting certain practices regarding the sale of substances containing tetrahydrocannabinol or industrial hemp extracts. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$513,374 |
Positions |
0.00 |
5.00 |
|
• |
Provide funding for organized retail crime task force |
Decision Package |
|
|
Provides funding to establish an organized retail crime task force, including staff and the procurement of a database network to allow cooperation with law enforcement to address organized retail crime across the Commonwealth. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$414,105 |
Positions |
0.00 |
3.00 |
|
• |
Provide funding for hemp legislation |
Decision Package |
|
|
Funds additional support for hemp regulation. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$371,780 |
Positions |
0.00 |
3.00 |
|
• |
Provide additional support for ratepayer advocacy |
Decision Package |
|
|
Funds additional support for ratepayer advocacy. |
|
|
FY 2023 |
FY 2024 |
General Fund |
$0 |
$253,902 |
Positions |
0.00 |
2.00 |
|
• |
Establish fund for the Commonwealth's share of opioid settlement funds |
Decision Package |
|
|
Establishes a new fund to house the Commonwealth's share of amounts from settlements, judgments, verdicts, or other court orders relating to consumer protection claims regarding the manufacturing, marketing, distribution, or sale of opioids, excluding amounts designated for transfer to the Opioid Abatement Authority. |